METHOD FOR OBTAINING NON NATURAL TRANSGENIC MOUSE AT DEFICIENCY OF GENE OF RECEPTOR 2 CORTICOLIBERIN (CRFR2) AND ITS APPLICATION Russian patent published in 2005 - IPC

Abstract RU 2251838 C2

FIELD: gene engineering.

SUBSTANCE: it is necessary to isolate genomic clone containing locus of CRFR2 gene. Then comes constructing a guide vector where exons 10,11 and 12 of CRFR2 are replaced with a cassette of selective marker gene, and its transfer into embryonic stem cells. Then comes injecting embryonic stem cells into blastocysts to be then transferred for pseudopregnant female mice. Finally, one should obtain homozygous according to destroyed allele CRFR2 gene. Moreover, it is suggested to apply the method for screening compounds that control blood pressure via the way of receptor 2 corticoliberin by applying the obtained transgenic mice. The innovation enables to obtain transgenic mice which do not express protein of receptor 2 corticoliberin in no allele. The innovation could be applied in the field of neurobiology, endocrinology and psychiatry to study anxiety and depression and, also, to obtain preparations for treating these diseases.

EFFECT: higher efficiency.

4 cl, 25 dwg, 17 ex

Similar patents RU2251838C2

Title Year Author Number
UROCORTIN PROTEINS AND THEIR USING 2001
  • Vehjl Uajli V.
  • Savchenko Pol F.
  • L'Juis Kehti Eh.
  • Vogan Dzhoan M.
  • Rehjs Tereza M.
  • Riv'Er Zhan E.
  • Khogenesh Dzhon B.
  • Perrin Mehrilin G.
RU2278871C2
METHOD FOR PREPARING TRANSGENIC MOUSE NO COMPRISING FUNCTIONAL RECEPTOR-1 CORTICOTROPIN RELEASING-FACTOR, METHOD FOR IDENTIFYING AGONIST OR ANTAGONIST OF CORTICOTROPIN RELEASING-FACTOR, UROCORTIN OR LIGAND OF CORTICOTROPIN RELEASING-FACTOR AND METHOD FOR SCREENING COMPOUNDS THAT ARE ANALOGS OR AGONISTS OF CORTICOSTERONE OR CORTICOTROPIN USING SUCH MOUSE 1999
  • Li Kuo-Fen
  • Vejl Vajli
RU2236127C2
COMPOSITIONS AND METHODS RELATED TO SOLUBLE G-PROTEIN CONJUGATE RECEPTORS (SGPCR) 2006
  • Chen Alon
  • Perrin Mehrilin
  • Vehjl Uajli
RU2423378C2
UROCORTIN-III, ITS ANALOG (VARIANTS) AND PHARMACEUTICAL COMPOSITION 2002
  • Vehjl Uajli V. Ml.
  • Riv'Er Zhan E.
  • Kunitake Koiti S.
  • L'Juis Kehti Eh.
  • Perrin Mehrilin G.
  • Dzhulias Dzhozef
RU2305109C2
METHODS FOR IDENTIFYING COMPOUNDS USED FOR REGULATION OF MUSCLE MASS OR FUNCTION WITH APPLYING RECEPTORS OF CORTICOTROPIN RELEASING-FACTOR 2002
  • Isfort Robert Dzhozef
  • Sheldon Rassell Dzhejms
RU2260805C2
NEW PEPTIDE INVOLVED IN ENERGY HOMEOSTASIS 2006
  • Batler Ehndrju A.
  • Trevaskis Dzhejms L.
RU2409590C2
SYSTEM DELIVERY AND REGULATED EXPRESSION OF PARACRINE GENES FOR TREATMENT OF CARDIOVASCULAR AND OTHER DISEASES 2013
  • Khemmond Kh. Kerk
  • Gao Mej Khua
RU2642605C2
REGULATION OF METABOLISM USING MIR-378 2011
  • Olson Eric N.
  • Carrer Michele
RU2585491C2
COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION AND TREATING NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS 2011
  • Rinsh Kristofer L.
  • Blanko-Boze Uilyam
  • Shnajder Bernard
  • Tomas Charlz
  • Sandi Karmen
  • Overks Jokhan
  • Andre Penelopa
  • Khutkuper Rikhardus
  • Pirinen Ejya
  • Mushirud Lorent
  • Genu David
RU2745439C2
COMPOSITIONS AND METHODS FOR IMPROVING OR MAINTAINING MUSCLE PERFORMANCE 2011
  • Rinsh Kristofer L.
  • Blanko-Boze Uilyam
  • Shnajder Bernard
  • Tomas Charlz
  • Sandi Karmen
  • Overks Jokhan
  • Andre Penelopa
  • Khutkuper Rikhardus
  • Pirinen Ejya
  • Mushirud Lorent
  • Genu David
RU2606763C2

RU 2 251 838 C2

Authors

Li Kuo-Fen

Behjl Trejsi L.

Smit Dzhordzh V.

Vehjl Uajli

Dates

2005-05-20Published

2000-07-14Filed